Antibody-based HIV-1 vaccines: Recent developments and future directions

被引：71

作者：

Montefiori, David ^{[1
]}

Sattentau, Quentin ^{[2
]}

Flores, Jorge ^{[3
]}

Esparza, Jose ^{[4
]}

Mascola, John ^{[5
]}

机构：

[1] Duke Univ, Med Ctr, Durham, NC 27706 USA

[2] Univ Oxford, Oxford, England

[3] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA

[4] Bill & Melinda Gates Fdn, Seattle, WA USA

[5] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA

来源：

PLOS MEDICINE | 2007年 / 4卷 / 12期

关键词：

D O I：

10.1371/journal.pmed.0040348

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1867 / 1871

页数：5

共 57 条

[1] Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type I infection [J].

Aasa-Chapman, MMI ;

Holuigue, S ;

Aubin, K ;

Wong, M ;

Jones, NA ;

Cornforth, D ;

Pellegrino, P ;

Newton, P ;

Williams, I ;

Borrow, P ;

Mcknight, A .

JOURNAL OF VIROLOGY, 2005, 79 (05) :2823-2830

[2] The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes [J].

Alam, S. Munir ;

McAdams, Mildred ;

Boren, David ;

Rak, Michael ;

Scearce, Richard M. ;

Gao, Feng ;

Camacho, Zenaido T. ;

Gewirth, Daniel ;

Kelsoe, Garnett ;

Chen, Pojen ;

Haynes, Barton F. .

JOURNAL OF IMMUNOLOGY, 2007, 178 (07) :4424-4435

[3] The global HIV/AIDS vaccine enterprise: Scientific strategic plan [J].

Bhan, MK ;

Berkley, S ;

DeWilde, M ;

Esparza, J ;

Fauci, AS ;

Gayle, H ;

Johnston, MI ;

Kaleebu, P ;

Kazatch-Kine, MD ;

Klausner, RD ;

Lander, ES ;

Makgoba, MW ;

Mocumbi, P ;

Piot, P ;

Quintana-Trias, O ;

Snow, W ;

Walport, MJ ;

Wigzell, H .

PLOS MEDICINE, 2005, 2 (02) :111-121

[4] Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].

Binley, JA ;

Wrin, T ;

Korber, B ;

Zwick, MB ;

Wang, M ;

Chappey, C ;

Stiegler, G ;

Kunert, R ;

Zolla-Pazner, S ;

Katinger, H ;

Petropoulos, CJ ;

Burton, DR .

JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252

[5] Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1 [J].

Binley, JM ;

Klasse, PJ ;

Cao, YZ ;

Jones, I ;

Markowitz, M ;

Ho, DD ;

Moore, JP .

JOURNAL OF VIROLOGY, 1997, 71 (04) :2799-2809

[6] CRYPTIC NATURE OF ENVELOPE V3 REGION EPITOPES PROTECTS PRIMARY MONOCYTOTROPIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM ANTIBODY NEUTRALIZATION [J].

BOUHABIB, DC ;

RODERIQUEZ, G ;

ORAVECZ, T ;

BERMAN, PW ;

LUSSO, P ;

NORCROSS, MA .

JOURNAL OF VIROLOGY, 1994, 68 (09) :6006-6013

[7]

BOWLEY DR, 2007, PROTEIN ENG DESIGN S, V20, P81090

[8] Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: Role of phosphate-binding subsites [J].

Brown, Bruce K. ;

Karasavvas, Nicos ;

Beck, Zoltan ;

Matyas, Gary R. ;

Birx, Deborah L. ;

Polonis, Victoria R. ;

Alving, Carl R. .

JOURNAL OF VIROLOGY, 2007, 81 (04) :2087-2091

[9] HIV vaccine design and the neutralizing antibody problem [J].

Burton, DR ;

Desrosiers, RC ;

Doms, RW ;

Koff, WC ;

Kwong, PD ;

Moore, JP ;

Nabel, GJ ;

Sodroski, J ;

Wilson, IA ;

Wyatt, RT .

NATURE IMMUNOLOGY, 2004, 5 (03) :233-236

[10] Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein [J].

Cao, J ;

Sullivan, N ;

Desjardin, E ;

Parolin, C ;

Robinson, J ;

Wyatt, R ;

Sodroski, J .

JOURNAL OF VIROLOGY, 1997, 71 (12) :9808-9812

← 1 2 3 4 5 6 →